logo

For the Inventor, By the Inventor

Glendale, AZ, United States of America

Carl Wagner

This inventor holds 18 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Pharmaceutical Compositions. Top assignees: Arizona State University, Other. Active years: 1976-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carl Wagner. Retrieved from https://idiyas.com/inventor/carl-wagner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 94.4

 

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 56(Granted Patents)


Location History:

  • Cushing, OK (US) (1976)
  • Avon Lake, OH (US) (1980)
  • Scottsdale, AZ (US) (2018 - 2019)
  • Glendale, AZ (US) (2015 - 2022)

Company Filing History:

goldMedal16 out of 2,171 
 
Arizona State University
 patents
silverMedal2 out of 834,659 
Other
 patents

Years Active: 1976-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Therapeutic Compounds
Pharmaceutical Compositions
RXR Agonist
RAR Agonist
Caffeic Acid Chelates
Dihydroindene Compounds
Tetrahydronaphthalene
Isochroman Compounds
Bexarotene Analogs
Naphthyl-Containing Compounds
Animal Disease Treatment
Light-Emitting Devices
18 patents (USPTO):Explore Patents
1. 12570616 - Therapeutic compounds (2026-03-10),
2. 12540121 - Compositions comprising a retinoid X receptor (RXR) agonist, a retinoic acid receptor (RAR) agonist, or a dual RXR/RAR agonist (2026-02-03),
3. 11458203 - Pharmaceutical compositions comprising caffeic acid chelates (2022-10-04),
4. 10787421 - Substituted anilines for treatment of animal diseases (2020-09-29),
5. 10391093 - Therapeutic compounds (2019-08-27),
6. 10328040 - Therapeutic methods (2019-06-25),
7. 10238655 - Dihydroindene and tetrahydronaphthalene compounds (2019-03-26),
8. 10238626 - Therapeutic compounds (2019-03-26),
9. 10231947 - Isochroman compounds and methods of use thereof (2019-03-19),
10. 10221143 - Substituted anilines for treatment of animal diseases (2019-03-05),
11. 10112917 - Therapeutic compounds (2018-10-30),
12. 10005741 - Therapeutic compounds (2018-06-26),
13. 9908856 - Therapeutic compounds (2018-03-06),
14. 9573906 - Therapeutic compounds (2017-02-21),
15. 9174917 - Bexarotene analogs (2015-11-03),

Title: The Innovative Journey of Carl Wagner

Introduction: Carl Wagner, a distinguished inventor hailing from Glendale, Arizona, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Carl Wagner's latest patents include a revolutionary solar-powered irrigation system designed to optimize water usage in agriculture, a cutting-edge drone technology for aerial mapping, and a state-of-the-art wearable health monitoring device.

Career Highlights: With over two decades of experience in the field of engineering and innovation, Carl Wagner has a proven track record of developing solutions that blend creativity with practicality. His work has been recognized with multiple awards, including the prestigious Innovation Excellence Award in 2018.

Collaborations: Throughout his career, Carl Wagner has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful commercialization of several groundbreaking technologies.

Conclusion: Carl Wagner's passion for innovation and his relentless pursuit of excellence continue to drive him towards creating technologies that have a positive impact on society. His dedication to pushing the boundaries of what is possible makes him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…